Biosyent (RX) Earns “Accumulate” Rating from Bloom Burton

Bloom Burton reiterated their accumulate rating on shares of Biosyent (CVE:RX) in a research report released on Thursday.

Shares of Biosyent stock opened at C$9.80 on Thursday. Biosyent has a 52 week low of C$7.30 and a 52 week high of C$11.00. The firm has a market capitalization of $139.88, a P/E ratio of 29.70 and a beta of 1.11.

How to Become a New Pot Stock Millionaire

Biosyent (CVE:RX) last issued its quarterly earnings data on Wednesday, March 21st. The company reported C$0.10 earnings per share for the quarter, meeting the Zacks’ consensus estimate of C$0.10. Biosyent had a return on equity of 25.90% and a net margin of 23.96%. The company had revenue of C$5.90 million during the quarter.

TRADEMARK VIOLATION NOTICE: This article was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3295778/biosyent-rx-earns-accumulate-rating-from-bloom-burton.html.

Biosyent Company Profile

BioSyent Inc is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc, acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women’s Health Unit, which commercializes pharmaceutical products focused on improving family and women’s health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business.

Receive News & Ratings for Biosyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biosyent and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Endologix  Stock Price Down 10.2%
Endologix Stock Price Down 10.2%
New Gold  Shares Gap Down to $2.49
New Gold Shares Gap Down to $2.49
InvestDigital  Price Hits $0.0556 on Exchanges
InvestDigital Price Hits $0.0556 on Exchanges
ICOBID  Price Hits $0.0013 on Exchanges
ICOBID Price Hits $0.0013 on Exchanges
SpaceChain  Market Cap Achieves $26.48 Million
SpaceChain Market Cap Achieves $26.48 Million
Patrick Industries, Inc.  Receives $75.25 Average Price Target from Analysts
Patrick Industries, Inc. Receives $75.25 Average Price Target from Analysts


© 2006-2018 Ticker Report. Google+.